Open AccessInactivation of SARS-CoV-2 on surfaces and in solution with Virusend (TX-10), a novel disinfectant
Author(s) -
Enyia R Anderson,
Grant L Hughes,
Edward I Patterson
Publication year - 2021
Publication title -
access microbiology
Language(s) - English
Resource type - Journals
ISSN - 2516-8290
DOI - 10.1099/acmi.0.000228
Subject(s) - disinfectant , covid-19 , pandemic , transmission (telecommunications) , virology , microbiology and biotechnology , biology , chemistry , medicine , computer science , infectious disease (medical specialty) , outbreak , disease , pathology , telecommunications , organic chemistry
Until an effective vaccine against SARS-CoV-2 is available on a widespread scale, the control of the COVID-19 pandemic is reliant upon effective pandemic control measures. The ability of SARS-CoV-2 to remain viable on surfaces and in aerosols, means indirect contact transmission can occur and there is an opportunity to reduce transmission using effective disinfectants in public and communal spaces. Virusend (TX-10), a novel disinfectant, has been developed as a highly effective disinfectant against a range of microbial agents. Here we investigate the ability of Virusend to inactivate SARS-CoV-2. Using surface and solution inactivation assays, we show that Virusend is able to reduce SARS-CoV-2 viral titre by 4 log 10 p.f.u. ml −1 within 1 min of contact. Ensuring disinfectants are highly effective against SARS-CoV-2 is important in eliminating environmental sources of the virus to control the COVID-19 pandemic.